Showing Results for
- Academic Journals (8)
Search Results
- 8
Academic Journals
- 8
-
From:PLoS ONE (Vol. 9, Issue 11) Peer-ReviewedBackground and Aims L-glutamine is an efficacious glucagon-like peptide (GLP)-1 secretagogue in vitro. When administered with a meal, glutamine increases GLP-1 and insulin excursions and reduces postprandial...
-
From:Diabetes (Vol. 59, Issue 9) Peer-ReviewedOBJECTIVE--Chronic low-grade inflammation is a feature of obesity and is postulated to be causal in the development of insulin resistance and type 2 diabetes. The aim of this study was to assess whether overfeeding...
-
From:PLoS ONE (Vol. 7, Issue 5) Peer-ReviewedAuthor(s): Dorit Samocha-Bonet 1 , 2 , Lesley V. Campbell 1 , 2 , Trevor A. Mori 3 , Kevin D. Croft 3 , Jerry R. Greenfield 1 , 2 , Nigel Turner 1 , 2 , Leonie K. Heilbronn 1 , 4 , * Introduction Obesity is...
-
From:Diabetes Care (Vol. 36, Issue 8) Peer-ReviewedOBJECTIVE--Glutamine reduces postprandial glycemia when given before oral glucose. We evaluated whether this is mediated by stimulation of insulin and/or slowing of gastric emptying. RESEARCH DESIGN AND METHODS--Ten...
-
From:PLoS ONE (Vol. 8, Issue 8) Peer-ReviewedBackground We recently reported significantly greater weight gain in non-diabetic healthy subjects with a 1.sup.st degree family history (FH+) of type 2 diabetes mellitus (T2DM) than in a matched control group...
-
From:eLife (Vol. 7) Peer-ReviewedInsulin resistance in muscle, adipocytes and liver is a gateway to a number of metabolic diseases. Here, we show a selective deficiency in mitochondrial coenzyme Q (CoQ) in insulin-resistant adipose and muscle tissue....